Completed
Pilot Study With GFT505 (80mg) in Atherogenic Dyslipidaemic Patients With Abdominal Obesity
NCT01271751
- Conditions
- Abdominal Obesity, Atherogenic Dyslipidaemia, Body Weight, +8 more
- Locations
-
- Site n°36 Aigrefeuille-sur-Maine, France
- Site n°78 Angers, France
- Site n°79 Angers, France
- Site n°80 Angers, France